Stay updated on Psilocybin in OCD: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the Psilocybin in OCD: Efficacy Study Clinical Trial page.

Latest updates to the Psilocybin in OCD: Efficacy Study Clinical Trial page
- Check5 days agoChange DetectedThe site’s footer revision identifier changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check12 days agoChange DetectedThe study record now displays the completed trial’s details, outcome measures, results-related information, and supporting documents, including the protocol and consent form.SummaryDifference68%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedA sitewide NIH transition announcement appears above the 403 error page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe site footer’s revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check61 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page. The page now shows a generic error layout instead of the study details.SummaryDifference21%

Stay in the know with updates to Psilocybin in OCD: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin in OCD: Efficacy Study Clinical Trial page.